Precigen, Inc. (PGEN)
3.89
+0.79
(+25.48%)
USD |
NASDAQ |
Mar 26, 16:00
3.82
-0.07
(-1.80%)
Pre-Market: 09:02
Precigen Profit Margin (Quarterly) : -514.9% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -154.4% |
| Amneal Pharmaceuticals, Inc. | 6.09% |
| Corcept Therapeutics, Inc. | 11.83% |
| CorMedix, Inc. | 10.90% |
| Viridian Therapeutics, Inc. | -77.26K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -901.1% |
| Return on Assets | -177.7% |
| Return on Invested Capital | -356.4% |
| Gross Profit Margin (Quarterly) | 58.07% |
| Operating Margin (Quarterly) | -474.6% |
| Return on Net Operating Assets | -573.7% |